FindTrial
Sign In

Evaluate The Effect of Unani Medicine in The Management of Hirsutism in Polycystic Ovarian Disease

Clinical Study Of Hirsutism (Kasarath-E-Shaar) & Its Management With Unani Drugs - nil

Status
Active, not recruiting
Phases
Phase 2Phase 3
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2024/05/066930
Enrollment
40
Registered
2024-05-07
Start date
Unknown
Completion date
Unknown
Last updated
2024-05-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: L680- Hirsutism

Interventions

Intervention1: Unani Formulation: Mode of Usage: Oral and Local Application : Decoctaion of Pudina Powder 10gm in 50ml of Water Once in a Day at Morning After Breakfast and Face Pack of Ajwian Kharasa

Sponsors

Pg Department of Obstetrics and GynaecologyIlmul Qabalath wa AmrazeNiswan
Lead Sponsor
Government Nizamia Tibbi College and General Hospital charminar
Collaborator

Eligibility

Inclusion criteria

Inclusion criteria: -Patient With Regular and Irregular Periods -Obesity -Hypothyroidism

Exclusion criteria

Exclusion criteria: -Pregnant Women -Genetic Disorders Like Cushing Syndrome,Ware Wolf Syndrome -Hypertrichosis -Women With Systemic Illness Like Liver Disorders,Kidney Disorders,DM Etc -Women With Allergic or Hypertensive to NSAIDS

Design outcomes

Primary

MeasureTime frame
Changes in Hormonal AssayTimepoint: Once in 3 Month,Pre and Post Test—

Secondary

MeasureTime frame
Reduction in Clinical Sign and Symptoms.Timepoint: At Baseline,2 weeks,4 weeks,8 weeks,12 weeks—

Countries

India

Contacts

Public ContactDr Y Amtul Mubeena

Govt.Nizamia Tibbi College and General Hospital,Charminar.

drasuhasini12@gmail.com9949586899

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026